HomeWho Are We?

Vaccizone is the inventor of a first-in-class vaccine development method aiming to help develop vaccines for terminal illnesses.

Based on 20 years of research conducted by the founder Prof. Nesrin Özören, Vaccizone developed and patented a novel method for an antigen/bioactive delivery which increases both the antigenicity of the antigen as well as enhancing its stability at high temperatures, freeze thaw cycles and organic solvents. Utilizing its unique platform, Vaccizone is helping pharma industry leaders and governments to save lives.


Vaccizone is developing next generation antigen delivery and vaccine technologies for human and animal diseases based on its novel ASC technology. We are building a platform that changes the vaccine and treatment development paradigm for preventable diseases.